Renaissance Technologies’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $517K | Buy |
190,673
+67,900
| +55% | +$184K | ﹤0.01% | 2813 |
|
2025
Q1 | $416K | Sell |
122,773
-24,400
| -17% | -$82.7K | ﹤0.01% | 2815 |
|
2024
Q4 | $606K | Buy |
147,173
+11,300
| +8% | +$46.6K | ﹤0.01% | 2758 |
|
2024
Q3 | $338K | Sell |
135,873
-900
| -0.7% | -$2.24K | ﹤0.01% | 2938 |
|
2024
Q2 | $361K | Buy |
136,773
+49,704
| +57% | +$131K | ﹤0.01% | 2839 |
|
2024
Q1 | $179K | Buy |
87,069
+17,896
| +26% | +$36.8K | ﹤0.01% | 3249 |
|
2023
Q4 | $125K | Buy |
69,173
+7,200
| +12% | +$13K | ﹤0.01% | 3246 |
|
2023
Q3 | $85K | Buy |
61,973
+1,600
| +3% | +$2.2K | ﹤0.01% | 3279 |
|
2023
Q2 | $83K | Buy |
60,373
+28,200
| +88% | +$38.8K | ﹤0.01% | 3513 |
|
2023
Q1 | $76K | Buy |
32,173
+2,500
| +8% | +$5.91K | ﹤0.01% | 3568 |
|
2022
Q4 | $68K | Sell |
29,673
-2,200
| -7% | -$5.04K | ﹤0.01% | 3728 |
|
2022
Q3 | $88K | Sell |
31,873
-300
| -0.9% | -$828 | ﹤0.01% | 3633 |
|
2022
Q2 | $79K | Buy |
32,173
+13,700
| +74% | +$33.6K | ﹤0.01% | 3902 |
|
2022
Q1 | $73K | Buy |
18,473
+4,800
| +35% | +$19K | ﹤0.01% | 3846 |
|
2021
Q4 | $60K | Sell |
13,673
-25,990
| -66% | -$114K | ﹤0.01% | 3763 |
|
2021
Q3 | $245K | Buy |
39,663
+18,556
| +88% | +$115K | ﹤0.01% | 3137 |
|
2021
Q2 | $167K | Sell |
21,107
-5,944
| -22% | -$47K | ﹤0.01% | 3281 |
|
2021
Q1 | $289K | Sell |
27,051
-16,200
| -37% | -$173K | ﹤0.01% | 3066 |
|
2020
Q4 | $666K | Buy |
43,251
+1,132
| +3% | +$17.4K | ﹤0.01% | 2698 |
|
2020
Q3 | $720K | Buy |
42,119
+6,826
| +19% | +$117K | ﹤0.01% | 2674 |
|
2020
Q2 | $291K | Buy |
35,293
+9,886
| +39% | +$81.5K | ﹤0.01% | 3053 |
|
2020
Q1 | $178K | Buy |
25,407
+88
| +0.3% | +$617 | ﹤0.01% | 3120 |
|
2019
Q4 | $264K | Buy |
25,319
+4,084
| +19% | +$42.6K | ﹤0.01% | 3099 |
|
2019
Q3 | $237K | Sell |
21,235
-1,513
| -7% | -$16.9K | ﹤0.01% | 3096 |
|
2019
Q2 | $414K | Buy |
22,748
+11,531
| +103% | +$210K | ﹤0.01% | 3068 |
|
2019
Q1 | $812K | Sell |
11,217
-1,772
| -14% | -$128K | ﹤0.01% | 2760 |
|
2018
Q4 | $374K | Sell |
12,989
-986
| -7% | -$28.4K | ﹤0.01% | 2956 |
|
2018
Q3 | $1.18M | Buy |
13,975
+3,109
| +29% | +$261K | ﹤0.01% | 2536 |
|
2018
Q2 | $1.37M | Buy |
10,866
+4,762
| +78% | +$600K | ﹤0.01% | 2462 |
|
2018
Q1 | $554K | Buy |
6,104
+922
| +18% | +$83.7K | ﹤0.01% | 2876 |
|
2017
Q4 | $379K | Buy |
5,182
+522
| +11% | +$38.2K | ﹤0.01% | 2952 |
|
2017
Q3 | $437K | Buy |
4,660
+1,172
| +34% | +$110K | ﹤0.01% | 2826 |
|
2017
Q2 | $367K | Buy |
3,488
+950
| +37% | +$100K | ﹤0.01% | 2843 |
|
2017
Q1 | $343K | Buy |
2,538
+321
| +14% | +$43.4K | ﹤0.01% | 2870 |
|
2016
Q4 | $351K | Buy |
2,217
+884
| +66% | +$140K | ﹤0.01% | 2869 |
|
2016
Q3 | $330K | Buy |
1,333
+1,248
| +1,468% | +$309K | ﹤0.01% | 2932 |
|
2016
Q2 | $76K | Sell |
85
-21
| -20% | -$18.8K | ﹤0.01% | 3196 |
|
2016
Q1 | $96K | Sell |
106
-154
| -59% | -$139K | ﹤0.01% | 3220 |
|
2015
Q4 | $368K | Buy |
+260
| New | +$368K | ﹤0.01% | 2826 |
|